Eamon M. Berge
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 9
- Renal cell carcinoma treatment 1
- Oncology 7
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Robert C. Doebele (11 shared papers)D. Ross Camidge (8 shared papers)Dara L. Aisner (5 shared papers)Marileila Varella‐Garcia (3 shared papers)Anh T. Le (3 shared papers)Mariana F. Theodoro (1 shared paper)Matteo Incarbone (1 shared paper)Kurtis D. Davies (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Thoracic Oncology (3 papers)Clinical Lung Cancer (2 papers)Clinical Cancer Research (1 paper)Drugs of today (1 paper)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Eamon M. Berge
14 papers receiving 537 citations
Eamon M. Berge's Hit Papers
Peers
Comparison fields: 5 of 41
- Pulmonary and Respiratory Medicine 390
- Oncology 228
- Cancer Research 98
- Molecular Biology 187
- Pathology and Forensic Medicine 25
Countries citing papers authored by Eamon M. Berge
This map shows the geographic impact of Eamon M. Berge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eamon M. Berge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eamon M. Berge more than expected).
Fields of papers citing papers by Eamon M. Berge
This network shows the impact of papers produced by Eamon M. Berge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eamon M. Berge. The network helps show where Eamon M. Berge may publish in the future.
Co-authors
The 25 scholars most cited alongside Eamon M. Berge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer Hit paper breakdown → | 2012 | 332 |
| 2 | 2013 | 48 | |
| 3 | 2015 | 44 | |
| 4 | 2014 | 41 | |
| 5 | 2013 | 20 | |
| 6 | 2012 | 18 | |
| 7 | 2013 | 8 | |
| 8 | 2013 | 8 | |
| 9 | 2013 | 6 | |
| 10 | 2014 | 6 | |
| 11 | 2011 | 5 | |
| 12 | 2013 | 4 | |
| 13 | 2012 | 3 | |
| 14 | 2012 | 1 |
About Eamon M. Berge
Eamon M. Berge is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 14 papers that have together received 544 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Research Studies (2 papers), Cancer therapeutics and mechanisms (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Genomics and Diagnostics (1 paper), Renal cell carcinoma treatment (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (390 citations), Oncology (228 citations), Cancer Research (98 citations), Molecular Biology (187 citations) and Pathology and Forensic Medicine (25 citations). Eamon M. Berge has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Robert C. Doebele, D. Ross Camidge, Dara L. Aisner, Marileila Varella‐Garcia, Anh T. Le, Mariana F. Theodoro, Matteo Incarbone, Kurtis D. Davies, Armando Santoro and Margaret C. Skokan. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Clinical Lung Cancer, Clinical Cancer Research and Drugs of today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.